20 May 2013
Keywords: alcon, expands, accord, origenis, licenses, gsk, cilomilast
Article | 20 October 2008
Alcon has signed a licensing deal with UK drug major GlaxoSmithKline for global ophthalmic rights to cilomilast, a phosphodiesterase IV
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
20 October 2008
17 May 2013
© 2013 thepharmaletter.com